Torres J - Search Results

1

Controversies in Inflammatory Bowel Disease: Exploring Clinical Dilemmas Using Cochrane Reviews.

East JE, Boyapati RK, Torres J, Parker CE, MacDonald JK, Chande N, Feagan BG. East JE, et al. Among authors: torres j. Inflamm Bowel Dis. 2019 Feb 21;25(3):472-478. doi: 10.1093/ibd/izy268. Inflamm Bowel Dis. 2019. PMID: 30789982 Review.

2

Ulcerative colitis as a progressive disease: the forgotten evidence.

Torres J, Billioud V, Sachar DB, Peyrin-Biroulet L, Colombel JF. Torres J, et al. Inflamm Bowel Dis. 2012 Jul;18(7):1356-63. doi: 10.1002/ibd.22839. Epub 2011 Dec 11. Inflamm Bowel Dis. 2012. PMID: 22162423 Review.

3

Immunosuppression in inflammatory bowel disease: how much is too much?

Cohen BL, Torres J, Colombel JF. Cohen BL, et al. Among authors: torres j. Curr Opin Gastroenterol. 2012 Jul;28(4):341-8. doi: 10.1097/MOG.0b013e328354567f. Curr Opin Gastroenterol. 2012. PMID: 22573191 Free PMC article. Review.

4

Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia.

Torres J, Bao X, Iuga AC, Chen A, Harpaz N, Ullman T, Cohen BL, Pineton de Chambrun G, Asciutti S, Odin JA, Sachar DB, Gaskins HR, Setchell K, Colombel JF, Itzkowitz SH. Torres J, et al. Inflamm Bowel Dis. 2013 Feb;19(2):275-82. doi: 10.1097/MIB.0b013e318286ff2e. Inflamm Bowel Dis. 2013. PMID: 23348121

5

Skin side effects of inflammatory bowel disease therapy.

Torres J, Buche S, Delaporte E, Colombel JF. Torres J, et al. Inflamm Bowel Dis. 2013 Apr;19(5):1086-98. doi: 10.1097/MIB.0b013e3182802c07. Inflamm Bowel Dis. 2013. PMID: 23474780 Review.

6

Review article: non-malignant oral manifestations in inflammatory bowel diseases.

Katsanos KH, Torres J, Roda G, Brygo A, Delaporte E, Colombel JF. Katsanos KH, et al. Among authors: torres j. Aliment Pharmacol Ther. 2015 Jul;42(1):40-60. doi: 10.1111/apt.13217. Epub 2015 Apr 28. Aliment Pharmacol Ther. 2015. PMID: 25917394 Review.

7

Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease.

Torres J, Boyapati RK, Kennedy NA, Louis E, Colombel JF, Satsangi J. Torres J, et al. Gastroenterology. 2015 Dec;149(7):1716-30. doi: 10.1053/j.gastro.2015.08.055. Epub 2015 Sep 14. Gastroenterology. 2015. PMID: 26381892 Free article. Review.

8

Genetics and phenotypes in inflammatory bowel disease.

Torres J, Colombel JF. Torres J, et al. Lancet. 2016 Jan 9;387(10014):98-100. doi: 10.1016/S0140-6736(15)00464-X. Epub 2015 Oct 18. Lancet. 2016. PMID: 26490194 Free article. No abstract available.

9

Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases.

Torres J, Caprioli F, Katsanos KH, Lobatón T, Micic D, Zerôncio M, Van Assche G, Lee JC, Lindsay JO, Rubin DT, Panaccione R, Colombel JF. Torres J, et al. J Crohns Colitis. 2016 Dec;10(12):1385-1394. doi: 10.1093/ecco-jcc/jjw116. Epub 2016 Jun 9. J Crohns Colitis. 2016. PMID: 27282402 Free PMC article.

10

Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease.

Boyapati RK, Torres J, Palmela C, Parker CE, Silverberg OM, Upadhyaya SD, Nguyen TM, Colombel JF. Boyapati RK, et al. Among authors: torres j. Cochrane Database Syst Rev. 2018 May 12;5(5):CD012540. doi: 10.1002/14651858.CD012540.pub2. Cochrane Database Syst Rev. 2018. PMID: 29756637 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,008 results

Search Page

Filters